Perceptive Advisors Acquires Significant Stake in Invivyd Inc: A Strategic Move in Biotechnology Sector
ByAinvest
Wednesday, Nov 26, 2025 10:51 am ET1min read
IVVD--
PERCEPTIVE ADVISORS LLC acquired 21.79 million shares of Invivyd Inc at $2.53 per share, representing a 1.57% position in its portfolio. The firm, known for strategic investments in biotechnology, has a $3.45 billion equity portfolio with significant holdings in companies like Ascendis Pharma AS and Celcuity Inc. Invivyd Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based solutions for infectious diseases. Despite current financial challenges, the acquisition highlights the firm's confidence in Invivyd Inc's long-term potential.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet